Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-01-26
1995-06-13
Lacey, David L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424 111, 424 129, 424422, 514965, 530362, 600 3, 600 4, A61K 3838, A61K 5100, C07K 1476, A61M 3600
Patent
active
054242886
ABSTRACT:
A method of treating solid tumor cancer in a living being by prolonging the time a therapeutically effective agent remains in the tumor. The method comprises the steps of selecting particles of an aggregated protein and injecting them interstitially into the tumor. The therapeutically effective agent colloidal radioactive phosphorous is injected into the tumor either after the injection of the proteinaceous particles, or simultaneously.
REFERENCES:
patent: Re33375 (1990-10-01), Luck et al.
TechneScan.RTM. MAA product literature, Kit for the Preparation of Technetium Tc 99m Albumin Aggregated, sold by Mallinckrodt Medical Inc., St. Louis, Mo, 63134, revised Sep. 1992, 1 page, 2 sides.
MPI MAA Kit brochure, Medi-Physics Inc, 1990.
Lacey David L.
Schwadron Ron
LandOfFree
Method of treating solid tumor cancers utilizing macro aggregate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating solid tumor cancers utilizing macro aggregate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating solid tumor cancers utilizing macro aggregate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1309364